Kiyoaki Ito

6.5k total citations
170 papers, 2.8k citations indexed

About

Kiyoaki Ito is a scholar working on Surgery, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kiyoaki Ito has authored 170 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Surgery, 75 papers in Epidemiology and 59 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kiyoaki Ito's work include Gallbladder and Bile Duct Disorders (52 papers), Liver Disease Diagnosis and Treatment (43 papers) and Hepatitis C virus research (40 papers). Kiyoaki Ito is often cited by papers focused on Gallbladder and Bile Duct Disorders (52 papers), Liver Disease Diagnosis and Treatment (43 papers) and Hepatitis C virus research (40 papers). Kiyoaki Ito collaborates with scholars based in Japan, United States and France. Kiyoaki Ito's co-authors include Masashi Mizokami, Yasuhito Tanaka, Masashi Yoneda, Etsuro Orito, Tadahisa Inoue, Yukiomi Nakade, Tomohiko Ohashi, Yuji Kobayashi, Masaya Sugiyama and Norimitsu Ishii and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Kiyoaki Ito

150 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kiyoaki Ito Japan 27 1.9k 1.5k 511 439 306 170 2.8k
Zu‐Yau Lin Taiwan 37 2.8k 1.5× 3.0k 2.0× 351 0.7× 538 1.2× 200 0.7× 205 4.3k
Akihiro Matsumoto Japan 37 3.3k 1.8× 3.1k 2.1× 576 1.1× 370 0.8× 163 0.5× 132 4.4k
Carlo Fabris Italy 29 1.7k 0.9× 1.5k 1.0× 478 0.9× 299 0.7× 145 0.5× 160 3.0k
Hiroshi Yatsuhashi Japan 38 2.9k 1.5× 3.0k 2.0× 500 1.0× 506 1.2× 160 0.5× 185 4.4k
Yoshiaki Katano Japan 30 1.4k 0.7× 1.2k 0.8× 676 1.3× 373 0.8× 303 1.0× 148 2.9k
Fusao Ikeda Japan 26 1.3k 0.7× 1.5k 1.0× 268 0.5× 320 0.7× 116 0.4× 115 2.3k
Hidenori Ochi Japan 36 2.7k 1.4× 2.3k 1.6× 358 0.7× 734 1.7× 120 0.4× 119 4.1k
Hans‐Peter Dienes Germany 31 2.2k 1.2× 2.3k 1.6× 753 1.5× 795 1.8× 165 0.5× 57 4.0k
Masahiko Kaito Japan 29 1.5k 0.8× 1.3k 0.9× 199 0.4× 539 1.2× 123 0.4× 85 2.8k
Kazuaki Inoue Japan 28 1.1k 0.6× 1.1k 0.8× 632 1.2× 686 1.6× 290 0.9× 107 2.8k

Countries citing papers authored by Kiyoaki Ito

Since Specialization
Citations

This map shows the geographic impact of Kiyoaki Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kiyoaki Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kiyoaki Ito more than expected).

Fields of papers citing papers by Kiyoaki Ito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kiyoaki Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kiyoaki Ito. The network helps show where Kiyoaki Ito may publish in the future.

Co-authorship network of co-authors of Kiyoaki Ito

This figure shows the co-authorship network connecting the top 25 collaborators of Kiyoaki Ito. A scholar is included among the top collaborators of Kiyoaki Ito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kiyoaki Ito. Kiyoaki Ito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Arai, Jun, Akinori Okumura, Kazumasa Sakamoto, et al.. (2025). Efficacy of measuring natural killer-activating receptor ligands to predict the pathogenesis of metabolic dysfunction-associated steatotic liver disease. Hepatology International. 19(4). 836–845. 2 indexed citations
3.
4.
Yamanaka, Takahiro, Kenichiro Araki, Takehiko Yokobori, et al.. (2024). Potential of Mac‐2‐binding protein glycan isomer as a new therapeutic target in pancreatic cancer. Cancer Science. 115(4). 1241–1249. 7 indexed citations
5.
6.
7.
Hara, Satoshi, Yoshinori Takahashi, Kiyoaki Ito, et al.. (2023). Case report: Rosai-Dorfman disease with rare extranodal lesions in the pelvis, heart, liver and skin. Frontiers in Oncology. 12. 1083500–1083500. 1 indexed citations
8.
9.
10.
Inoue, Tadahisa, Rena Kitano, Kazumasa Sakamoto, et al.. (2023). Comparison of the mechanical properties of retrieval basket catheters for bile duct stones: An experimental study. Indian Journal of Gastroenterology. 42(5). 651–657. 1 indexed citations
11.
Inoue, Tadahisa, Itaru Naitoh, Rena Kitano, et al.. (2022). Endobiliary Radiofrequency Ablation Combined with Gemcitabine and Cisplatin in Patients with Unresectable Extrahepatic Cholangiocarcinoma. Current Oncology. 29(4). 2240–2251. 14 indexed citations
12.
Hara, Satoshi, et al.. (2022). Normotensive Scleroderma Renal Crisis 8 Years After Living Donor Renal Transplantation: A Case Report. Journal of the American Society of Nephrology. 33(11S). 841–841.
13.
Kawahara, Hiroyuki, Ichiro Mizushima, Seung Yong Shin, et al.. (2022). Clues to mortality trends and their related factors in IgG4-related disease: A Japanese single-centre retrospective study. Modern Rheumatology. 33(6). 1154–1161. 2 indexed citations
14.
Ito, Kiyoaki, Akinori Okumura, Junko S. Takeuchi, et al.. (2021). Dual Agonist of Farnesoid X Receptor and Takeda G Protein‐Coupled Receptor 5 Inhibits Hepatitis B Virus Infection In Vitro and In Vivo. Hepatology. 74(1). 83–98. 33 indexed citations
15.
Honda, Fumika, Hiroto Tsuboi, Saori Abe, et al.. (2021). Pathogenic roles and therapeutic potential of the CCL8–CCR8 axis in a murine model of IgG4-related sialadenitis. Arthritis Research & Therapy. 23(1). 214–214. 10 indexed citations
16.
Onoe, Tamehito, Satoshi Hara, Kazunori Yamada, et al.. (2021). Significance of kidney biopsy in autosomal dominant tubulointerstitial kidney disease-UMOD: is kidney biopsy truly nonspecific?. BMC Nephrology. 22(1). 1–1. 15 indexed citations
17.
Nakade, Yukiomi, Taeko Yamauchi, Kazumasa Sakamoto, et al.. (2017). Influence of nicotine on choline-deficient, L-amino acid-defined diet-induced non-alcoholic steatohepatitis in rats. PLoS ONE. 12(6). e0180475–e0180475. 5 indexed citations
18.
Yotsuyanagi, Hiroshi, Yasuhito Tanaka, Akihiko Saitoh, et al.. (2012). Universal vaccination of hepatitis B virus vaccine. Kanzo. 53(2). 117–130. 2 indexed citations
19.
20.
Garcia, Tamako, Jisu Li, Camille Sureau, et al.. (2009). Drastic Reduction in the Production of Subviral Particles Does Not Impair Hepatitis B Virus Virion Secretion. Journal of Virology. 83(21). 11152–11165. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zu‐Yau Lin Breakdown of academic impact, for papers by Akihiro Matsumoto Breakdown of academic impact, for papers by Carlo Fabris Breakdown of academic impact, for papers by Hiroshi Yatsuhashi Breakdown of academic impact, for papers by Yoshiaki Katano Breakdown of academic impact, for papers by Fusao Ikeda Breakdown of academic impact, for papers by Hidenori Ochi Breakdown of academic impact, for papers by Hans‐Peter Dienes Breakdown of academic impact, for papers by Masahiko Kaito Breakdown of academic impact, for papers by Kazuaki Inoue
Rankless by CCL
2026